Tirzepatide 15mg/30mg Research Peptide | Dual GLP-1/GIP Agonist | Metabolic Research | COA Verified

$100.00

Category:

Description

For Research Purposes Only. Not approved for human consumption. Tirzepatide Research Peptide Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly — the first-in-class twincretin peptide. In Phas

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide 15mg/30mg Research Peptide | Dual GLP-1/GIP Agonist | Metabolic Research | COA Verified”

Your email address will not be published. Required fields are marked *